Advice

Expert commentators

Expert commentators

The following clinicians contributed to this briefing:

  • Dr Christopher Parrish, consultant haematologist, Leeds Teaching Hospitals NHS Trust. Participated in advisory board for Everything Genetic Ltd.

  • Prof Gordon Cook, professor of haematology and clinical director of National Institute for Health Research (NIHR) Leeds Medtech and In Vitro Diagnostics Cooperative, University of Leeds. Did not declare any interests.

  • Prof Guy Pratt, consultant haematologist, University Hospitals Birmingham. Participated in advisory board for Everything Genetic Ltd.

  • Dr Martin Kaiser, research team leader and consultant haematologist, Royal Marsden Hospital and the Institute of Cancer Research, London, UK. Has provided unpaid technical advice for SkylineDx in relation to SKY92 as part of research performed in the OPTIMUM/MUKnine trial.

  • Dr Kevin Boyd, consultant haemato-oncologist, The Royal Marsden NHS Foundation Trust. Did not declare any interests.